Skip to main content
. 2012 Nov 13;10:222. doi: 10.1186/1479-5876-10-222

Table 2.

Type and line of therapy, treatment response and CTCs results before and during the course of therapy from 33 colorectal cancer patients

PatientID Therapy Line of therapy Staging outcome CTCs before therapy CTCs during therapy
1–4 weeks 5–8 weeks 9–12 weeks
5
 FOLFIRI+Beva
 2
 PD
 +
 -
 -
 +
7
 FUFOX
 2
 PD
 +
 +
 +
 +
8
 FOLFIRI+Beva
 2
 NP
 +
 +
 +
 -
9
 FUFIRI
 2
 PD
 +
 +
 +
 +
15
 FOLFIRI
 1
 PD
 -
 +
 +
 +
36
 FOLFOX-4
 1
 PD
 +
 -
 +
 +
39
 FUFIRI
 2
 PD
 +
 -
 -
 -
47
 FOLFIRI+Beva
 1
 NP
 +
 -
 -
 -
49
 FOLFOX-4
 1
 NP
 +
 -
 +
 -
49
 FOLFIRI
 2
 PD
 +
 +
 +
 +
65
 Panitumumab
 2
 NP
 -
 -
 +
 -
65
 Panitumumab
 2
 PD
 +
 +
 +
 +
70
 FOLFOX-4
 1
 NP
 -
 -
 +
 -
73
 FOLFOX-4
 1
 PD
 +
 -
 -
 +
74
 FOLFIRI+Beva
 2
 PD
 +
 +
 +
 +
77
 AIO+Beva
 1
 NP
 +
 +
 +
 -
80
 FOLFIRI+Beva
 1
 NP
 -
 -
 -
 -
81
 FUFIRI
 1
 PD
 -
 +
 +
 +
81
 FUFOX
 2
 PD
 +
 +
 +
 +
87
 AIO
 1
 NP
 +
 -
 -
 +
91
 AIO +Beva
 2
 NP
 -
 -
 -
 -
97
 FOLFIRI +Beva
 1
 NP
 +
 +
 +
 +
97
 FOLFIRI +Beva
 1
 PD
 +
 +
 +
 -
99
 FOLFOX-4
 1
 NP
 -
 -
 -
 -
109
 AIO
 1
 PD
 +
 +
 +
 +
112
 FOLFIR+Beva
 1
 NP
 -
 +
 -
 -
139
 FOLFIR+Beva
 1
 NP
 +
 +
 -
 -
150
 AIO +Beva
 1
 NP
 -
 -
 -
 -
151
 FUFOX
 1
 NP
 +
 +
 -
 +
151
 FUFOX
 1
 PD
 +
 +
 +
 +
171
 FOLFOX-4
 1
 NP
 +
 -
 -
 -
184
 AIO
 1
 NP
 -
 -
 -
 -
195 AIO 1 PD + + + +